Novel pharmacotherapy for fibromyalgia.

1: Expert Opin Investig Drugs. 2007 Jun;16(6):829-41.

Wood PB, Holman AJ, Jones KD.

Louisiana State University Health Sciences Center–Shreveport, Department of Family Medicine, Shreveport, LA 71130, USA. pwood@lsuhsc.edu

Fibromyalgia is a common disorder that is characterized by chronic widespread pain, tenderness to light palpation, fatigue and sleep disturbances. The present lack of a well-accepted model of the disorder has hampered progress towards adequate treatment. A review of potential models to explain the pathophysiology underlying its primary symptom (i.e., chronic widespread pain) lends insight on the therapeutic potential of novel therapies. Following this, a mechanistic evaluation of those medications that are under consideration for the treatment of the disorder is offered. Adequate treatment will be likely to involve the identification of biologic subgroups within the greater fibromyalgia construct. Key insights from basic research are the basis for increased optimism for effective relief among patients and clinicians.

PMID: 17501695 [PubMed – in process]

FMS Global News

Tenderpoints

Advertisements

About FMS Global News

Folllowing Rick Usher's death in December 2008, at his request in September of that year, I had agreed, as his principal contributor and an experienced journalist, to run the FMS Global News service due to his heavy commitments to music and raising research funds through this avenue. Following his sad and sudden death I hope to continue his work as he would have wished.
This entry was posted in Article, Awareness, Back Pain, Britain, Chronic Pain, Chronic Widespread Pain, Clinical Pain, Drugs, Europe, Feeds, Fibrohugs, Fibromyalgia, Fibromyalgia Blogs, Fibromyalgia News, Fibromyalgia News Belgium, Fibromyalgia News Deutschland, Fibromyalgia News France, Fibromyalgia News Israel, Fibromyalgia News Italy, Fibromyalgia News Japan, Fibromyalgia News Jerusalem, Fibromyalgia News Korea, Fibromyalgia News Southeast Asia, Fibromyalgia News Turkey, Fibromyalgia Press Releases, Fibromyalia News Germany, FMS Global News, Global News, Health, Hypersensitivity, Invisible Illness, Invisible Illnesses, Medical, Medical Journals, Medical Research, Medical University, Multiple Chemical Sensitivity, Myofacial Pain Syndrome, Narcotics, News, News Australia, News Belgium, News Canada, News France, News India, News Ireland, News Israel, News Italy, News Japan, News Jerusalem, News Korea, News Montreal, News Nigeria, News Norway, News Quebec, News Saskatchewan, News Scotland, News Spain, News Sweden, News Turkey, News UK, Nigeria, North Carolina, Ontario, Ottawa, Pain, Pain Management, Pain Matrix, Palliative Care, Pharmacologic, Philadelphia, Physiology, Research, Rheumatism, Rheumatoid Arthritis, RSS, Sleep Disorders, Sleep Disturbance, Sleep Quality, Statistics, Stockholm, Swedish, Tenderpoints, Therapies, Toronto, Universities, US, Virginia, Washington DC, World, WORLD FIBROMYALGIA DAY, World News, World Wide. Bookmark the permalink.

One Response to Novel pharmacotherapy for fibromyalgia.

  1. Pingback: University Update

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s